Lihe Kechuang: Lihe Yunji has not carried out experimental verification against monkeypox virus yet
Lihe Kechuang said on the interactive platform that Lihe Yunji has not carried out experimental verification against monkeypox virus yet. Liheyunji's self disinfection and sterilization anti-virus functional material has the advantages of efficacy durability, safety and broad-spectrum effectiveness, and has not been applied to the field of mask production.
This text is a result of machine translation.
Related companies：
Briefing Jun 10, 2022 02:09 PM
· Technology
Ningde times: the industrialization layout of sodium ion battery has been started, and a basic industrial chain will be formed in 2023
Briefing Jun 01, 2022 10:34 AM
· Consumer Staples
China Merchants Securities: maintain the "recommended" rating on Alibaba and look forward to the development prospect of global business
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Briefing May 24, 2022 02:24 PM
· Healthcare
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
Jan 30, 2026 06:00 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Briefing May 21, 2022 06:44 AM
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Briefing May 20, 2022 04:58 AM
· Healthcare
Several new funds have actively picked up chips to speed up the pace of position building
Consumer Staples, Mobility, Embodied AI
Unpacking China | Key Chinese Firms to Watch This Week （12/04/2026-17/04/2026）
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Apr 17, 2026 05:51 PM
Healthcare
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Briefing May 10, 2022 04:20 PM
· Healthcare
Nintendo expects profit to fall by 29% this fiscal year and switch sales to 21 million units
In-depth
Healthcare, Automotive · Analysis
Manufacturing Glass for the Automobile Industry: Fuyao Group
You may remember Fuyao from the 2019 Netflix documentary, 'American Factory.' While the documentary lays out the story of the Chinese company’s foray into America based on social issues, here you will find out about the business side.
May 27, 2020 07:45 PM
Briefing Apr 18, 2022 10:18 PM
· Technology
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Briefing Mar 15, 2022 04:28 PM
· Technology
Anhui Construction Engineering Group Co., Ltd.: the consortium won the bid for the project with a total of 3.242 billion yuan
See more
Read next
Insight
In-depth
Embodied AI · Analysis
Chinese Embodied AI Company AI² Robotics: The Real Bottleneck in Embodied AI Is Scenarios, Not Just AI
Apr 14, 2026 11:25 AM
Insight
In-depth
Technology, Embodied AI · Analysis
From 0 to 2.6 million units, Ecovacs Window Robot makes "first choice" the only answer.
Apr 10, 2026 07:00 PM
Insight
In-depth
Insight
In-depth
Embodied AI · Analysis
Investment Is Booming, Orders Are Rising, but Robots Are Still Learning How to Deliver
Mar 23, 2026 10:29 AM